Prestige Ameritech has received NIOSH and FDA approval to market its new N95 Particulate Filter Respirator and Surgical Mask in time for the 2010 flu season. The new respirator will be sold by Owens & Minor and other distributors. Prestige Ameritech was recently awarded contracts for N95 respirators and surgical masks by the Premier and Med Assets group purchasing organizations.
Â
The ProGearTM N95 Respirator has the highest fluid-resistance rating available, a larger-than-normal filter area for easier breathing and speaking, soft stretch-knit headbands for increased comfort, and a convenient dispensing method.
Â
Were going to show the healthcare industry that respirators dont have to be bulky, uncomfortable or expensive to be effective, says Dan Reese, president of Prestige Ameritech.
Â
Prestige Ameritechs new N95 respirator is another step toward its goal of placing Americas surgical mask and respirator supply back under American control. Much of America's surgical mask and respirator supply is currently imported. Prestige Ameritech is Americas largest domestic manufacturer of surgical masks. Prestige Ameritechs 220,000-square-foot Global Pandemic Preparedness and Response Center is located near Dallas.
CDC HICPAC Considers New Airborne Pathogen Guidelines Amid Growing Concerns
November 18th 2024The CDC HICPAC discussed updates to airborne pathogen guidelines, emphasizing the need for masks in health care. Despite risks, the committee resisted universal masking, highlighting other mitigation strategies
Breaking the Cycle: Long COVID's Impact and the Urgent Need for Preventative Measures
November 15th 2024Masking, clean air, and vaccinations are essential in combating COVID-19 and preventing long-term impacts, as evidence mounts of long COVID's significant economic, cognitive, and behavioral effects.
The Critical Role of Rapid Diagnostics in Antibiotic Stewardship
November 6th 2024Rapid diagnostics enhance patient outcomes by enabling prompt, targeted treatments, reducing inappropriate antibiotic use, and combating antimicrobial resistance through informed clinical decisions and stewardship programs.